PATENT CLAIM ANALYSIS

Application Number: 16135134
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "243100"]

Abstract:
The disclosure generally relates to the field of prevention and treatment of  Staphylococcus aureus  infections. In particular, the disclosure relates to immunogens comprising  Staphylococcus aureus  antigens and methods for generating immune reponses to immunogens, and to antibody products specific for the  Staphylococcus aureus  epitopes and methods for treating  Staphylococcus aureus  infection with the antibody products.

Claim (Index 12):
The method of  claim 11  wherein the antibody product comprises the heavy chain CDRs set out in SEQ ID NOs: 2, 3 and 4 and the light chain CDRs set out in SEQ ID NO: 5, 6 and 7.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.78788
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15511827', '15845701', '14440749', '13719214', '13983804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7358808974878306
- 35 USC 102 Novelty (BERT): 0.6679707071650572
- Combined Prediction Score: 0.7290898784555533
- Mean Citation Score: 453.762476
- Max Citation Score: 742.5386
- Similarity Product: 603.395287844038

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test